For this reason, although also recently it was used as the sole marker of CSCs [19], CD133 belongs to a well-known panel of molecules that, when properly combined, can actually identify cells with a stem-like phenotype in breast cancer cell lines and primary tumors with different phenotypes [13, 20]. The gene discussed is PROM1; the disease is breast carcinoma.